Current Assets

Restricted Cash

Moderna Restricted Cash decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. Over 2 years (FY 2020 to FY 2022), Restricted Cash shows an upward trend with a 241.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.

Detailed definition

Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...

Peer comparison

Common in capital-intensive industries like energy where project financing requires specific reserve accounts.

Metric ID: restricted_cash

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$0.00$0.00$12.00M$12.00M$12.00M$0.00$12.00M$0.00$21.00M$17.00M$17.00M$0.00$0.00$1.00M$1.00M$1.00M$0.00
QoQ Change+0.0%+0.0%-100.0%-100.0%-19.0%+0.0%-100.0%+0.0%+0.0%-100.0%
YoY Change+0.0%-100.0%+75.0%-100.0%-100.0%-94.1%-100.0%
Range$0.00$21.00M
Avg YoY Growth-59.9%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Moderna's restricted cash?
Moderna (MRNA) reported restricted cash of $0.00 in Q1 2026.
How has Moderna's restricted cash changed year-over-year?
Moderna's restricted cash decreased by 100.0% year-over-year, from $1.00M to $0.00.
What is the long-term trend for Moderna's restricted cash?
Over 2 years (2020 to 2022), Moderna's restricted cash has grown at a 241.0% compound annual growth rate (CAGR), from $1.03M to $12.00M.
What does restricted cash mean?
Cash that is legally tied up and cannot be used for day-to-day operations.